| 000 | 01502 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515172448.0 | ||
| 264 | 0 | _c20090915 | |
| 008 | 200909s 0 0 fre d | ||
| 022 | _a1166-7087 | ||
| 024 | 7 |
_a10.1016/j.purol.2009.02.006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPerrouin-Verbe, B | |
| 245 | 0 | 0 |
_a[Criteria and best clinical practice guidelines for first intradetrusor injection of botulinum toxin type A to treat neurogenic detrusor overactivity]. _h[electronic resource] |
| 260 |
_bProgres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie _cJun 2009 |
||
| 300 |
_a372-82 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 |
_aBotulinum Toxins, Type A _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections |
| 650 | 0 | 4 |
_aNeuromuscular Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aUrinary Bladder, Neurogenic _xdrug therapy |
| 700 | 1 | _aRuffion, A | |
| 700 | 1 | _aGamé, X | |
| 700 | 1 | _aDenys, P | |
| 700 | 1 | _aKerdraon, J | |
| 700 | 1 | _aKarsenty, G | |
| 700 | 1 | _ade Sèze, M | |
| 700 | 1 | _aHaab, F | |
| 700 | 1 | _aSaussine, C | |
| 700 | 1 | _aSoler, J-M | |
| 700 | 1 | _aAmarenco, G | |
| 700 | 1 | _aChartier-Kastler, E | |
| 773 | 0 |
_tProgres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie _gvol. 19 _gno. 6 _gp. 372-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.purol.2009.02.006 _zAvailable from publisher's website |
| 999 |
_c18893308 _d18893308 |
||